NeoGenomics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving NeoGenomics, Inc. now
Current reporting with the operating signal separated from the noise.
Which Is a Better Investment, NeoGenomics, Inc. or GeneDx Holdings Corp. Stock?
Investors are testing whether NeoGenomics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call Transcript
Investors are testing whether NeoGenomics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest NEO filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
NeoGenomics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →